SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-17-040561
Filing Date
2017-02-13
Accepted
2017-02-13 16:27:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 1 d280193dsc13ga.htm SC 13G/A 30362
  Complete submission text file 0001193125-17-040561.txt   31870
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Subject) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87209 | Film No.: 17599544
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 TIMES SQUARE 42ND FLOOR NEW YORK NY 10036
Business Address 7 TIMES SQUARE 42ND FLOOR NEW YORK NY 10036 800-541-5156
TimesSquare Capital Management, LLC (Filed by) CIK: 0001313816 (see all company filings)

IRS No.: 201665304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A